FAM230F: A Potential Drug Target and Biomarker (G100996432)

Target Name: FAM230F

NCBI ID: G100996432

FAM230F

Other Name(s): LOC100996432 | Paternally-expressed gene 3 protein-like | family with sequence similarity 230 member F | LINC01663

FAM230F: A Potential Drug Target and Biomarker

FAM230F is a gene that has been identified as a potential drug target and biomarker for various diseases, including cancer, neurodegenerative diseases, and autoimmune disorders. The gene is located on chromosome 16 and encodes for a protein known as FAM230F.

The FAM230F protein is a transmembrane protein that is involved in various cellular processes, including cell signaling, inflammation, and stress resistance. It is a key regulator of the T-cell receptor (TCR), which is a critical protein that plays a central role in immune surveillance against infections and tumors.

FAM230F has been shown to be involved in the regulation of T-cell development, immune response, and cancer progression. It has been shown to promote the development of cancer cells, and it has also been shown to contribute to the development of neurodegenerative diseases.

FAM230F has also been shown to be involved in the regulation of inflammation. It has been shown to protect against oxidative stress and inflammation, and it has been shown to play a key role in the regulation of inflammation-related diseases.

FAM230F has also been shown to be involved in stress resistance. It has been shown to protect against stress-induced cellular death, and it has also been shown to play a key role in the regulation of stress-related diseases.

In conclusion, FAM230F is a gene that has been shown to be involved in various cellular processes that are important for human health and wellbeing. As a potential drug target and biomarker, FAM230F may be a valuable tool for the development of new treatments for a variety of diseases.

Protein Name: Family With Sequence Similarity 230 Member F

The "FAM230F Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about FAM230F comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets